Genomic Health (GHDX) Tops Q1 EPS by 5c

May 4, 2016 4:40 PM EDT

Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.19), $0.05 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $80.9 million versus the consensus estimate of $78.12 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings